{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:02:39Z","timestamp":1793275359773,"version":"4.5.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1054,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS100849"],"award-info":[{"award-number":["R01NS100849"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08NS109287"],"award-info":[{"award-number":["K08NS109287"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01RX002987"],"award-info":[{"award-number":["I01RX002987"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13311-020-00963-x","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T14:02:30Z","timestamp":1605621750000},"page":"1495-1510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Approach to Cognitive Impairment in Parkinson's Disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Qiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina M.","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandakumar S.","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4430-6960","authenticated-orcid":false,"given":"Ergun Y.","family":"Uc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"issue":"12","key":"10.1007\/s13311-020-00963-x_bib2","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cger.2020.01.001","article-title":"Cognitive impairment and dementia in Parkinson disease","volume":"36","author":"Goldman","year":"2020","journal-title":"Clin Geriatr Med"},{"issue":"12","key":"10.1007\/s13311-020-00963-x_bib4","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1212\/01.wnl.0000191565.11065.11","article-title":"Visual dysfunction in Parkinson disease without dementia","volume":"65","author":"Uc","year":"2005","journal-title":"Neurology."},{"issue":"4","key":"10.1007\/s13311-020-00963-x_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1017\/S1355617710000470","article-title":"Prediction of driving ability with neuropsychological tests: demographic adjustments diminish accuracy","volume":"16","author":"Barrash","year":"2010","journal-title":"J Int Neuropsychol Soc"},{"issue":"7","key":"10.1007\/s13311-020-00963-x_bib6","first-page":"616","article-title":"Driving under low-contrast visibility conditions in Parkinson disease (vol 73, pg 1103, 2009)","volume":"74","author":"Uc","year":"2010","journal-title":"Neurology"},{"issue":"22","key":"10.1007\/s13311-020-00963-x_bib7","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1212\/WNL.0b013e31821d74fa","article-title":"Real-life driving outcomes in Parkinson disease","volume":"76","author":"Uc","year":"2011","journal-title":"Neurology."},{"issue":"5","key":"10.1007\/s13311-020-00963-x_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/mds.25870","article-title":"Cognitive impairment and dementia in Parkinson's disease: practical issues and management","volume":"29","author":"Emre","year":"2014","journal-title":"Mov Disord"},{"issue":"19","key":"10.1007\/s13311-020-00963-x_bib9","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1212\/WNL.0000000000004629","article-title":"Longitudinal decline of driving safety in Parkinson disease","volume":"89","author":"Uc","year":"2017","journal-title":"Neurology."},{"issue":"11","key":"10.1007\/s13311-020-00963-x_bib10","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/mds.21030","article-title":"Time of loss of employment in Parkinson's disease","volume":"21","author":"Schrag","year":"2006","journal-title":"Mov Disord"},{"issue":"Pt 8","key":"10.1007\/s13311-020-00963-x_bib11","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/brain\/awm142","article-title":"Patterns of levodopa response in Parkinson's disease: a clinico-pathological study","volume":"130","author":"Kempster","year":"2007","journal-title":"Brain."},{"issue":"13","key":"10.1007\/s13311-020-00963-x_bib12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study","volume":"72","author":"Aarsland","year":"2009","journal-title":"Neurology."},{"issue":"12","key":"10.1007\/s13311-020-00963-x_bib13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e3181f39d0e","article-title":"Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis","volume":"75","author":"Aarsland","year":"2010","journal-title":"Neurology."},{"issue":"4","key":"10.1007\/s13311-020-00963-x_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","article-title":"Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study","volume":"82","author":"Yarnall","year":"2014","journal-title":"Neurology."},{"issue":"4","key":"10.1007\/s13311-020-00963-x_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1212\/WNL.0b013e31829c5c86","article-title":"Evolution of mild cognitive impairment in Parkinson disease","volume":"81","author":"Broeders","year":"2013","journal-title":"Neurology."},{"issue":"10","key":"10.1007\/s13311-020-00963-x_bib16","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mds.23823","article-title":"MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI","volume":"26","author":"Litvan","year":"2011","journal-title":"Mov Disord"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1007\/s13311-020-00963-x_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Mov Disord"},{"issue":"7","key":"10.1007\/s13311-020-00963-x_bib19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/mds.27002","article-title":"Mild cognitive impairment as a risk factor for Parkinson's disease dementia","volume":"32","author":"Hoogland","year":"2017","journal-title":"Mov Disord"},{"issue":"18","key":"10.1007\/s13311-020-00963-x_bib20","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1212\/WNL.0b013e3181bf992f","article-title":"Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort","volume":"73","author":"Uc","year":"2009","journal-title":"Neurology."},{"key":"10.1007\/s13311-020-00963-x_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41531-018-0055-3","article-title":"Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health","volume":"4","author":"Goldman","year":"2018","journal-title":"NPJ Parkinsons Dis"},{"issue":"9996","key":"10.1007\/s13311-020-00963-x_bib22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet."},{"issue":"2 Dementia","key":"10.1007\/s13311-020-00963-x_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/CON.0000000000000309","article-title":"Lewy body dementias: dementia with lewy bodies and Parkinson disease dementia","volume":"22","author":"Gomperts","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"issue":"10004","key":"10.1007\/s13311-020-00963-x_bib24","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet."},{"key":"10.1007\/s13311-020-00963-x_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fneur.2018.00123","article-title":"Parkinson's disease dementia and dementia with Lewy bodies have similar neuropsychological profiles","volume":"9","author":"Aldridge","year":"2018","journal-title":"Front Neurol"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1037\/neu0000230","article-title":"Distinguishing Alzheimer's disease and dementia with Lewy bodies using cognitive and olfactory measures","volume":"30","author":"Westervelt","year":"2016","journal-title":"Neuropsychology."},{"issue":"1","key":"10.1007\/s13311-020-00963-x_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology."},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00697388","article-title":"Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease","volume":"61","author":"Arendt","year":"1983","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1007\/s13311-020-00963-x_bib30","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study","volume":"60","author":"Bohnen","year":"2003","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1515\/revneuro-2013-0004","article-title":"Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease","volume":"24","author":"Narayanan","year":"2013","journal-title":"Rev Neurosci"},{"issue":"5","key":"10.1007\/s13311-020-00963-x_bib32","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/ana.25236","article-title":"Serotonin, beta-amyloid, and cognition in Parkinson disease","volume":"83","author":"Kotagal","year":"2018","journal-title":"Ann Neurol"},{"issue":"2-3","key":"10.1007\/s13311-020-00963-x_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","article-title":"The vulnerable ventral tegmental area in Parkinson's disease","volume":"5","author":"Alberico","year":"2015","journal-title":"Basal Ganglia"},{"issue":"19","key":"10.1007\/s13311-020-00963-x_bib34","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","article-title":"The MoCA: well-suited screen for cognitive impairment in Parkinson disease","volume":"75","author":"Dalrymple-Alford","year":"2010","journal-title":"Neurology."},{"issue":"15","key":"10.1007\/s13311-020-00963-x_bib35","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/mds.23362","article-title":"A recommended scale for cognitive screening in clinical trials of Parkinson's disease","volume":"25","author":"Chou","year":"2010","journal-title":"Mov Disord"},{"issue":"1","key":"10.1007\/s13311-020-00963-x_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11065-006-9002-x","article-title":"Executive function and the frontal lobes: a meta-analytic review","volume":"16","author":"Alvarez","year":"2006","journal-title":"Neuropsychol Rev"},{"issue":"24","key":"10.1007\/s13311-020-00963-x_bib37","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib38","first-page":"1611","article-title":"Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: a meta-analysis","volume":"17","author":"Meng","year":"2019","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib39","first-page":"276","article-title":"Parkinson's disease-related visual hallucinations unresponsive to atypical antipsychotics treated with cholinesterase inhibitors: a case series","volume":"41","author":"Sobow","year":"2007","journal-title":"Neurol Neurochir Pol"},{"issue":"12","key":"10.1007\/s13311-020-00963-x_bib40","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/jnnp-2018-318107","article-title":"Early use of donepezil against psychosis and cognitive decline in Parkinson's disease: a randomised controlled trial for 2 years","volume":"89","author":"Sawada","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1007\/s13311-020-00963-x_bib41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/00222895.2013.817380","article-title":"Striatal denervation pattern predicts levodopa effects on sequence learning in Parkinson's disease","volume":"45","author":"Kwak","year":"2013","journal-title":"J Mot Behav"},{"issue":"13","key":"10.1007\/s13311-020-00963-x_bib42","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1016\/j.neuropsychologia.2008.07.011","article-title":"A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism","volume":"46","author":"Moustafa","year":"2008","journal-title":"Neuropsychologia."},{"issue":"6","key":"10.1007\/s13311-020-00963-x_bib43","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.neuropsychologia.2004.10.001","article-title":"Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease","volume":"43","author":"Lewis","year":"2005","journal-title":"Neuropsychologia."},{"issue":"12","key":"10.1007\/s13311-020-00963-x_bib44","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.biopsych.2011.03.028","article-title":"Inverted-U-shaped dopamine actions on human working memory and cognitive control","volume":"69","author":"Cools","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1007\/s13311-020-00963-x_bib45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fnhum.2016.00523","article-title":"Pramipexole increases go timeouts but not no-go errors in healthy volunteers","volume":"10","author":"Yang","year":"2016","journal-title":"Front Hum Neurosci"},{"key":"10.1007\/s13311-020-00963-x_bib46","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3389\/fnhum.2017.00642","article-title":"Dopaminergic therapy increases go timeouts in the go\/no-go task in patients with Parkinson's disease","volume":"11","author":"Yang","year":"2017","journal-title":"Front Hum Neurosci"},{"issue":"9","key":"10.1007\/s13311-020-00963-x_bib47","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/mds.25082","article-title":"Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class","volume":"27","author":"Bliwise","year":"2012","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-020-00963-x_bib48","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3389\/fneur.2020.00708","article-title":"Effects of levodopa on impairments to high-level vision in Parkinson's disease","volume":"11","author":"Anderson","year":"2020","journal-title":"Front Neurol"},{"issue":"6","key":"10.1007\/s13311-020-00963-x_bib49","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.39.6.762","article-title":"Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test","volume":"39","author":"Pillon","year":"1989","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-020-00963-x_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/neurol-india.Neurol-India-D-24-00455","article-title":"Verbal and visual memory in patients with early Parkinson's disease: effect of levodopa","volume":"54","author":"Singh","year":"2006","journal-title":"Neurol India"},{"issue":"Pt 6","key":"10.1007\/s13311-020-00963-x_bib51","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/brain\/119.6.2121","article-title":"Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels","volume":"119","author":"Kulisevsky","year":"1996","journal-title":"Brain."},{"issue":"11","key":"10.1007\/s13311-020-00963-x_bib52","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1212\/WNL.38.11.1802","article-title":"Spatial disorientation in Parkinson's disease: no effect of levodopa substitution therapy","volume":"38","author":"Hovestadt","year":"1988","journal-title":"Neurology."},{"key":"10.1007\/s13311-020-00963-x_bib53","first-page":"572743","article-title":"Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function","volume":"2011","author":"Macdonald","year":"2011","journal-title":"Parkinsons Dis"},{"key":"10.1007\/s13311-020-00963-x_bib54","doi-asserted-by":"crossref","first-page":"260896","DOI":"10.1155\/2014\/260896","article-title":"Dopamine treatment and cognitive functioning in individuals with Parkinson's disease: the \u201ccognitive flexibility\u201d hypothesis seems to work","volume":"2014","author":"Costa","year":"2014","journal-title":"Behav Neurol"},{"issue":"4","key":"10.1007\/s13311-020-00963-x_bib55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/cjn.2018.21","article-title":"Effects of antiparkinson medication on cognition in Parkinson's disease: a systematic review","volume":"45","author":"Roy","year":"2018","journal-title":"Can J Neurol Sci"},{"issue":"10","key":"10.1007\/s13311-020-00963-x_bib56","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrn1764","article-title":"What makes us tick? Functional and neural mechanisms of interval timing","volume":"6","author":"Buhusi","year":"2005","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"10.1007\/s13311-020-00963-x_bib57","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1212\/01.WNL.0000072263.03608.42","article-title":"Effects of levodopa on motor sequence learning in Parkinson's disease","volume":"60","author":"Feigin","year":"2003","journal-title":"Neurology."},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/psyg.12294","article-title":"Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test","volume":"18","author":"Allone","year":"2018","journal-title":"Psychogeriatrics."},{"issue":"10","key":"10.1007\/s13311-020-00963-x_bib59","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1136\/jnnp-2013-307053","article-title":"Attention! A good bedside test for delirium?","volume":"85","author":"O'Regan","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1007\/s13311-020-00963-x_bib60","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41583-019-0189-2","article-title":"Striatal circuits for reward learning and decision-making","volume":"20","author":"Cox","year":"2019","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"10.1007\/s13311-020-00963-x_bib61","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a Frontal Assessment Battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology."},{"issue":"4","key":"10.1007\/s13311-020-00963-x_bib62","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1007\/s13311-020-00963-x_bib63","doi-asserted-by":"crossref","unstructured":"Schnider A Chapter 6 Neuropsychological testing: bedside approaches. Handbook of Clinical Neurology. 88: Elsevier; 2008. p. Pages 137-54.","DOI":"10.1016\/S0072-9752(07)88006-7"},{"key":"10.1007\/s13311-020-00963-x_bib64","doi-asserted-by":"crossref","unstructured":"Luria AR. Higher Cortical Functions in Man. 2d ed. New York: Basic Books : Consultants Bureau; 1980. xxii, 634 p. p.","DOI":"10.1007\/978-1-4615-8579-4"},{"key":"10.1007\/s13311-020-00963-x_bib65","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3389\/fneur.2019.01338","article-title":"Behavioral and neuroanatomical account of impulsivity in Parkinson's disease","volume":"10","author":"Hlavata","year":"2019","journal-title":"Front Neurol"},{"key":"10.1007\/s13311-020-00963-x_bib66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neubiorev.2017.02.018","article-title":"The relationship between impulse control disorders and cognitive dysfunctions in Parkinson's disease: a meta-analysis","volume":"77","author":"Santangelo","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156720506776383031","article-title":"Cholinesterase inhibitors slow decline in executive functions, rather than memory, in Alzheimer's disease: a 1-year observational study in the Sunnybrook dementia cohort","volume":"3","author":"Behl","year":"2006","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib68","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/WAD.0b013e31825c85ae","article-title":"Rivastigmine in the treatment of hypersexuality in Alzheimer disease","volume":"27","author":"Canevelli","year":"2013","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/JCP.0b013e3181d35c14","article-title":"Inappropriate sexual behaviors associated with donepezil treatment: a case report","volume":"30","author":"Lo Coco","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1007\/s13311-020-00963-x_bib70","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.2147\/NDT.S145916","article-title":"Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson's disease","volume":"13","author":"Murakami","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1007\/s13311-020-00963-x_bib71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fneur.2012.00159","article-title":"The epidemiology and clinical manifestations of dysexecutive syndrome in Parkinson's disease","volume":"3","author":"Ceravolo","year":"2012","journal-title":"Front Neurol"},{"issue":"Pt 12","key":"10.1007\/s13311-020-00963-x_bib72","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/brain\/124.12.2503","article-title":"Mechanisms of cognitive set flexibility in Parkinson's disease","volume":"124","author":"Cools","year":"2001","journal-title":"Brain."},{"issue":"5","key":"10.1007\/s13311-020-00963-x_bib73","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/JCP.0b013e3182979830","article-title":"A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs","volume":"33","author":"Poletti","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1007\/s13311-020-00963-x_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nicl.2016.11.004","article-title":"Executive attention networks show altered relationship with default mode network in PD","volume":"13","author":"Boord","year":"2017","journal-title":"Neuroimage Clin"},{"issue":"6","key":"10.1007\/s13311-020-00963-x_bib75","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/nan.12024","article-title":"Disturbed sleep in Parkinson's disease: anatomical and pathological correlates","volume":"39","author":"Kalaitzakis","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"9","key":"10.1007\/s13311-020-00963-x_bib76","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jagp.2013.01.072","article-title":"The dementia cognitive fluctuation scale, a new psychometric test for clinicians to identify cognitive fluctuations in people with dementia","volume":"22","author":"Lee","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"10.1007\/s13311-020-00963-x_bib77","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1176\/jnp.16.4.409","article-title":"The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies","volume":"16","author":"Simard","year":"2004","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"10.1007\/s13311-020-00963-x_bib78","first-page":"CD012494","article-title":"Cholinesterase inhibitors for the treatment of delirium in non-ICU settings","volume":"6","author":"Yu","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"10.1007\/s13311-020-00963-x_bib79","first-page":"S282","article-title":"Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture","volume":"59","author":"Marcantonio","year":"2011","journal-title":"J Am Geriatr Soc"},{"issue":"s1","key":"10.1007\/s13311-020-00963-x_bib80","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.3233\/JPD-202103","article-title":"Management of visual dysfunction in patients with Parkinson's disease","volume":"10","author":"Savitt","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.1007\/s13311-020-00963-x_bib81","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3389\/fphar.2019.01379","article-title":"The pharmacology of visual hallucinations in synucleinopathies","volume":"10","author":"Russo","year":"2019","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1007\/s13311-020-00963-x_bib82","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","article-title":"Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study","volume":"4","author":"Williams","year":"2005","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1007\/s13311-020-00963-x_bib83","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10072-016-2631-9","article-title":"Utility of Boston Qualitative Scoring System for Rey-Osterrieth Complex Figure: evidence from a Parkinson's diseases sample","volume":"37","author":"Scarpina","year":"2016","journal-title":"Neurol Sci"},{"issue":"16","key":"10.1007\/s13311-020-00963-x_bib84","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1523\/JNEUROSCI.2405-16.2017","article-title":"Cholinergic, but not dopaminergic or noradrenergic, enhancement sharpens visual spatial perception in humans","volume":"37","author":"Gratton","year":"2017","journal-title":"J Neurosci"},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/psyg.12089","article-title":"Long-term efficacy of donepezil for relapse of visual hallucinations in patients with dementia with Lewy bodies","volume":"15","author":"Ukai","year":"2015","journal-title":"Psychogeriatrics."},{"issue":"764","key":"10.1007\/s13311-020-00963-x_bib86","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/pgmj.65.764.358","article-title":"Visual hallucinations in the elderly associated with the use of levodopa","volume":"65","author":"Banerjee","year":"1989","journal-title":"Postgrad Med J"},{"key":"10.1007\/s13311-020-00963-x_bib87","doi-asserted-by":"crossref","unstructured":"Mattavelli G, Barvas E, Longo C, Zappini F, Ottaviani D, Malaguti MC, et al. Facial expressions recognition and discrimination in Parkinson's disease. J Neuropsychol 2020.","DOI":"10.1111\/jnp.12209"},{"key":"10.1007\/s13311-020-00963-x_bib88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neubiorev.2019.07.011","article-title":"Social perceptual function in parkinson's disease: a meta-analysis","volume":"104","author":"Coundouris","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1007\/s13311-020-00963-x_bib89","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1038\/s41598-020-61310-w","article-title":"Impairments in face discrimination and emotion recognition are related to aging and cognitive dysfunctions in Parkinson's disease with dementia","volume":"10","author":"Ho","year":"2020","journal-title":"Sci Rep"},{"issue":"11","key":"10.1007\/s13311-020-00963-x_bib90","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1523\/JNEUROSCI.17-11-04302.1997","article-title":"The fusiform face area: a module in human extrastriate cortex specialized for face perception","volume":"17","author":"Kanwisher","year":"1997","journal-title":"J Neurosci"},{"issue":"6","key":"10.1007\/s13311-020-00963-x_bib91","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0028-3932(99)00133-5","article-title":"Understanding memory for faces in Parkinson's disease: the role of configural processing","volume":"38","author":"Cousins","year":"2000","journal-title":"Neuropsychologia."},{"issue":"9","key":"10.1007\/s13311-020-00963-x_bib92","doi-asserted-by":"crossref","first-page":"e74044","DOI":"10.1371\/journal.pone.0074044","article-title":"Differential effects of Parkinson's disease and dopamine replacement on memory encoding and retrieval","volume":"8","author":"MacDonald","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1007\/s13311-020-00963-x_bib93","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","article-title":"Pathologic accumulation of alpha-synuclein and Abeta in Parkinson disease patients with dementia","volume":"69","author":"Kotzbauer","year":"2012","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1007\/s13311-020-00963-x_bib94","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/mds.27665","article-title":"Modifiable risk factors for cognitive impairment in Parkinson's disease: a systematic review and meta-analysis of prospective cohort studies","volume":"34","author":"Guo","year":"2019","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-020-00963-x_bib95","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fnins.2015.00293","article-title":"Disease-modifying therapeutic directions for Lewy-body dementias","volume":"9","author":"Zhang","year":"2015","journal-title":"Front Neurosci"},{"issue":"3 Suppl B","key":"10.1007\/s13311-020-00963-x_bib96","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1177\/0269881198012003021","article-title":"Selective serotonin reuptake inhibitors in affective disorders\u2013I. Basic pharmacology","volume":"12","author":"Goodnick","year":"1998","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib97","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-020-00963-x_bib98","doi-asserted-by":"crossref","unstructured":"Andrade C Anticholinergic drug exposure and the risk of dementia: there is modest evidence for an association but not for causality. J Clin Psychiatry. 2019;80(4).","DOI":"10.4088\/JCP.19f13000"},{"issue":"1","key":"10.1007\/s13311-020-00963-x_bib99","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2013.01.002","article-title":"Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study","volume":"64","author":"Wagg","year":"2013","journal-title":"Eur Urol"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5213\/inj.2040082.041","article-title":"Cognitive function and urologic medications for lower urinary tract symptoms","volume":"24","author":"Kim","year":"2020","journal-title":"Int Neurourol J"},{"issue":"8273","key":"10.1007\/s13311-020-00963-x_bib101","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(82)92206-1","article-title":"Antiemetics: neurotransmitter receptor binding predicts therapeutic actions","volume":"1","author":"Peroutka","year":"1982","journal-title":"Lancet."},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib102","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mdc3.12899","article-title":"Practical evaluation and management of insomnia in Parkinson's disease: a review","volume":"7","author":"Wallace","year":"2020","journal-title":"Mov Disord Clin Pract"},{"issue":"5","key":"10.1007\/s13311-020-00963-x_bib103","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/cns.12076","article-title":"High-dose donepezil (23 mg\/day) for the treatment of moderate and severe Alzheimer's disease: drug profile and clinical guidelines","volume":"19","author":"Cummings","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1007\/s13311-020-00963-x_bib104","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/CIA.S129145","article-title":"Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia","volume":"12","author":"Kandiah","year":"2017","journal-title":"Clin Interv Aging"},{"issue":"1","key":"10.1007\/s13311-020-00963-x_bib105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WNF.0000000000000010","article-title":"Long-term safety of rivastigmine in Parkinson disease dementia: an open-label, randomized study","volume":"37","author":"Emre","year":"2014","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1007\/s13311-020-00963-x_bib106","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/jnnp-2013-306439","article-title":"Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial","volume":"85","author":"Devos","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1007\/s13311-020-00963-x_bib107","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/mds.25098","article-title":"Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study","volume":"27","author":"Dubois","year":"2012","journal-title":"Mov Disord"},{"issue":"6","key":"10.1007\/s13311-020-00963-x_bib108","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/jnnp.72.6.708","article-title":"Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study","volume":"72","author":"Aarsland","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1007\/s13311-020-00963-x_bib109","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jnnp.2004.050682","article-title":"Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study","volume":"76","author":"Ravina","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1007\/s13311-020-00963-x_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gps.993","article-title":"Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease","volume":"19","author":"Leroi","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.1007\/s13311-020-00963-x_bib111","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ana.23557","article-title":"Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial","volume":"72","author":"Mori","year":"2012","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib112","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jnnp-2014-307659","article-title":"Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis","volume":"86","author":"Wang","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1007\/s13311-020-00963-x_bib113","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaneurol.2018.2820","article-title":"Patterns of dementia treatment and frank prescribing errors in older adults with Parkinson disease","volume":"76","author":"Mantri","year":"2019","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1007\/s13311-020-00963-x_bib114","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/mds.22495","article-title":"Randomized controlled trial of memantine in dementia associated with Parkinson's disease","volume":"24","author":"Leroi","year":"2009","journal-title":"Mov Disord"},{"issue":"7","key":"10.1007\/s13311-020-00963-x_bib115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","article-title":"Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial","volume":"8","author":"Aarsland","year":"2009","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1007\/s13311-020-00963-x_bib116","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Emre","year":"2010","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib117","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3233\/JAD-2005-8307","article-title":"Exacerbation of Lewy bodies dementia due to memantine","volume":"8","author":"Menendez-Gonzalez","year":"2005","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib118","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/01.wnl.0000172351.95783.8e","article-title":"Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine","volume":"65","author":"Ridha","year":"2005","journal-title":"Neurology."},{"issue":"7","key":"10.1007\/s13311-020-00963-x_bib119","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mds.26236","article-title":"Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study","volume":"30","author":"Mamikonyan","year":"2015","journal-title":"Mov Disord"},{"issue":"13","key":"10.1007\/s13311-020-00963-x_bib120","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","article-title":"A double-blind, delayed-start trial of rasagiline in Parkinson's disease","volume":"361","author":"Olanow","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1007\/s13311-020-00963-x_bib121","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/mds.23738","article-title":"The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study","volume":"26","author":"Hanagasi","year":"2011","journal-title":"Mov Disord"},{"issue":"5","key":"10.1007\/s13311-020-00963-x_bib122","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mds.26617","article-title":"Rasagiline for mild cognitive impairment in Parkinson's disease: a placebo-controlled trial","volume":"31","author":"Weintraub","year":"2016","journal-title":"Mov Disord"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib123","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mdc3.12455","article-title":"A randomized clinical trial of atomoxetine for mild cognitive impairment in Parkinson's disease","volume":"4","author":"Hinson","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"10.1007\/s13311-020-00963-x_bib124","series-title":"Neuromodulation","first-page":"3","article-title":"Chapter 1 - what is neuromodulation?","author":"Krames","year":"2009"},{"issue":"22","key":"10.1007\/s13311-020-00963-x_bib125","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1056\/NEJMoa0907083","article-title":"Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease","volume":"362","author":"Follett","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1007\/s13311-020-00963-x_bib126","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa060281","article-title":"A randomized trial of deep-brain stimulation for Parkinson's disease","volume":"355","author":"Deuschl","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1007\/s13311-020-00963-x_bib127","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pneurobio.2005.09.005","article-title":"The functional role of the subthalamic nucleus in cognitive and limbic circuits","volume":"76","author":"Temel","year":"2005","journal-title":"Prog Neurobiol"},{"issue":"1","key":"10.1007\/s13311-020-00963-x_bib128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/brain\/awx300","article-title":"A human prefrontal-subthalamic circuit for cognitive control","volume":"141","author":"Kelley","year":"2018","journal-title":"Brain."},{"issue":"12","key":"10.1007\/s13311-020-00963-x_bib129","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1162\/jocn_a_01012","article-title":"Startle habituation and midfrontal theta activity in Parkinson disease","volume":"28","author":"Chen","year":"2016","journal-title":"J Cogn Neurosci"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib130","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.clinph.2019.12.399","article-title":"Frontal theta and beta oscillations during lower-limb movement in Parkinson's disease","volume":"131","author":"Singh","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.1007\/s13311-020-00963-x_bib131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuropsychologia.2018.05.020","article-title":"Mid-frontal theta activity is diminished during cognitive control in Parkinson's disease","volume":"117","author":"Singh","year":"2018","journal-title":"Neuropsychologia."},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib132","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1152\/jn.00412.2015","article-title":"Medial frontal approximately 4-Hz activity in humans and rodents is attenuated in PD patients and in rodents with cortical dopamine depletion","volume":"114","author":"Parker","year":"2015","journal-title":"J Neurophysiol"},{"issue":"11","key":"10.1007\/s13311-020-00963-x_bib133","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1523\/JNEUROSCI.4674-12.2013","article-title":"The organization of prefrontal-subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: implications for basal ganglia models and deep brain stimulation","volume":"33","author":"Haynes","year":"2013","journal-title":"J Neurosci"},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib134","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-0102(02)00027-5","article-title":"Functional significance of the cortico\u2013subthalamo\u2013pallidal \u2018hyperdirect\u2019 pathway","volume":"43","author":"Nambu","year":"2002","journal-title":"Neurosci Res"},{"issue":"1-2","key":"10.1007\/s13311-020-00963-x_bib135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2008.06.010","article-title":"The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease","volume":"273","author":"Heo","year":"2008","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1007\/s13311-020-00963-x_bib136","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1212\/WNL.0000000000002401","article-title":"GPi vs STN deep brain stimulation for Parkinson disease: three-year follow-up","volume":"86","author":"Odekerken","year":"2016","journal-title":"Neurology."},{"key":"10.1007\/s13311-020-00963-x_bib137","unstructured":"Freund HJ, Kuhn J, Lenartz D, Mai JK, Schnell T, Klosterkoetter J, Sturm V, et al. Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. (1538-3687 (Electronic))."},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib138","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3233\/JAD-180121","article-title":"Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): a two year follow-up including results of delayed activation","volume":"64","author":"Leoutsakos","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"10.1007\/s13311-020-00963-x_bib139","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1093\/brain\/awy266","article-title":"Cognitive control involves theta power within trials and beta power across trials in the prefrontal-subthalamic network","volume":"141","author":"Zavala","year":"2018","journal-title":"Brain J Neurol"},{"key":"10.1007\/s13311-020-00963-x_bib140","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuroimage.2016.05.031","article-title":"Human subthalamic nucleus-medial frontal cortex theta phase coherence is involved in conflict and error related cortical monitoring","volume":"137","author":"Zavala","year":"2016","journal-title":"Neuroimage."},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib141","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.brs.2017.11.014","article-title":"A pilot study of subthalamic theta frequency deep brain stimulation for cognitive dysfunction in Parkinson's disease","volume":"11","author":"Scangos","year":"2018","journal-title":"Brain Stimul"},{"key":"10.1007\/s13311-020-00963-x_bib142","doi-asserted-by":"crossref","unstructured":"Wojtecki L, Elben S, Timmermann L, Reck C, Maarouf M, Jorgens S, et al. Modulation of human time processing by subthalamic deep brain stimulation. PLoS One. 2011;6(9).","DOI":"10.1371\/journal.pone.0024589"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib143","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00001756-199902250-00027","article-title":"Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson's disease","volume":"10","author":"Siebner","year":"1999","journal-title":"Neuroreport."},{"issue":"9","key":"10.1007\/s13311-020-00963-x_bib144","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/mds.20508","article-title":"Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression","volume":"20","author":"Boggio","year":"2005","journal-title":"Mov Disord"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0165-0173(01)00158-8","article-title":"Transcranial magnetic stimulation and Parkinson's disease","volume":"38","author":"Cantello","year":"2002","journal-title":"Brain Res Rev"},{"issue":"7","key":"10.1007\/s13311-020-00963-x_bib146","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/s00415-016-8160-x","article-title":"Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease","volume":"263","author":"Shin","year":"2016","journal-title":"J Neurol"},{"key":"10.1007\/s13311-020-00963-x_bib147","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2019.07.006","article-title":"Transcranial magnetic stimulation improves cognition over time in Parkinson's disease","volume":"66","author":"Trung","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"10.1007\/s13311-020-00963-x_bib148","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/1545968317712468","article-title":"Cognitive training and noninvasive brain stimulation for cognition in Parkinson's disease: a meta-analysis","volume":"31","author":"Lawrence","year":"2017","journal-title":"Neurorehabil Neural Repair"},{"issue":"5","key":"10.1007\/s13311-020-00963-x_bib149","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41593-019-0371-x","article-title":"Working memory revived in older adults by synchronizing rhythmic brain circuits","volume":"22","author":"Reinhart","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-020-00963-x_bib150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2014.08.043","article-title":"Effects of tDCS on executive function in Parkinson's disease","volume":"582","author":"Doruk","year":"2014","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib151","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ana.23951","article-title":"Adaptive deep brain stimulation in advanced Parkinson disease","volume":"74","author":"Little","year":"2013","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"10.1007\/s13311-020-00963-x_bib152","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.parkreldis.2015.09.028","article-title":"Adaptive deep brain stimulation in Parkinson's disease","volume":"22","author":"Beudel","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1007\/s13311-020-00963-x_bib153","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1152\/jn.00412.2015","article-title":"Medial frontal \u223c4-Hz activity in humans and rodents is attenuated in PD patients and in rodents with cortical dopamine depletion","volume":"114","author":"Parker","year":"2015","journal-title":"J Neurophysiol"},{"key":"10.1007\/s13311-020-00963-x_bib154","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2020.08.001","article-title":"Linear predictive coding distinguishes spectral EEG features of Parkinson's disease","volume":"79","author":"Anjum","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"10.1007\/s13311-020-00963-x_bib155","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1073\/pnas.0400266101","article-title":"Cardiovascular fitness, cortical plasticity, and aging","volume":"101","author":"Colcombe","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1007\/s13311-020-00963-x_bib156","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2015.9617","article-title":"Effect of a 24-month physical activity intervention vs health education on cognitive outcomes in sedentary older adults: the LIFE Randomized Trial","volume":"314","author":"Sink","year":"2015","journal-title":"JAMA."},{"issue":"9","key":"10.1007\/s13311-020-00963-x_bib157","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jama.300.9.1027","article-title":"Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial","volume":"300","author":"Lautenschlager","year":"2008","journal-title":"JAMA."},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib158","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/PSY.0b013e3181d14633","article-title":"Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials","volume":"72","author":"Smith","year":"2010","journal-title":"Psychosom Med"},{"issue":"5","key":"10.1007\/s13311-020-00963-x_bib159","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/WNL.0000000000000644","article-title":"Phase I\/II randomized trial of aerobic exercise in Parkinson disease in a community setting","volume":"83","author":"Uc","year":"2014","journal-title":"Neurology."},{"issue":"12","key":"10.1007\/s13311-020-00963-x_bib160","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/mds.26291","article-title":"Exercise improves cognition in Parkinson's disease: the PRET-PD randomized, clinical trial","volume":"30","author":"David","year":"2015","journal-title":"Mov Disord"},{"issue":"3","key":"10.1007\/s13311-020-00963-x_bib161","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/cercor\/10.3.295","article-title":"Emotion, decision making and the orbitofrontal cortex","volume":"10","author":"Bechara","year":"2000","journal-title":"Cereb Cortex"},{"key":"10.1007\/s13311-020-00963-x_bib162","unstructured":"Beck JS, Beck JS. Cognitive Behavior Therapy: Basics and Beyond. 2nd ed. New York: Guilford Press; 2011. xix, 391 p. p."},{"key":"10.1007\/s13311-020-00963-x_bib163","unstructured":"Bernstein DA, Borkovec TD. Progressive Relaxation Training: a Manual for the Helping Professions. Champaign, Ill.: Research Press; 1973. viii, 66 p. p."},{"issue":"23","key":"10.1007\/s13311-020-00963-x_bib164","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1212\/WNL.0000000000001043","article-title":"Improving functional disability and cognition in Parkinson disease: randomized controlled trial","volume":"83","author":"Pena","year":"2014","journal-title":"Neurology."},{"issue":"21","key":"10.1007\/s13311-020-00963-x_bib165","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1212\/WNL.0000000000002145","article-title":"Cognitive training in Parkinson disease: a systematic review and meta-analysis","volume":"85","author":"Leung","year":"2015","journal-title":"Neurology."},{"issue":"15","key":"10.1007\/s13311-020-00963-x_bib166","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.0b013e3182a823ba","article-title":"Randomized trial of cognitive speed of processing training in Parkinson disease","volume":"81","author":"Edwards","year":"2013","journal-title":"Neurology."},{"issue":"8","key":"10.1007\/s13311-020-00963-x_bib167","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10072-014-1666-z","article-title":"Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study","volume":"35","author":"Cerasa","year":"2014","journal-title":"Neurol Sci"},{"key":"10.1007\/s13311-020-00963-x_bib168","first-page":"CD011961","article-title":"Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease","volume":"2","author":"Orgeta","year":"2020","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00963-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00963-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00963-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:59:40Z","timestamp":1761807580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923012552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":168,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1878747923012552"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00963-x","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to Cognitive Impairment in Parkinson's Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00963-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}